Skip to main content
Top
Published in: Clinical Rheumatology 7/2016

01-07-2016 | Original Article

Assessment of vascular function in systemic onset juvenile idiopathic arthritis

Authors: Betul Sozeri, Basak Yildiz Atikan, Kadriye Ozdemir, Sevgi Mir

Published in: Clinical Rheumatology | Issue 7/2016

Login to get access

Abstract

An increased incidence of cardiovascular disease has been found in rheumatic disorders. Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Prolonged immunological inflammatory process leads these patients to an early onset of atherosclerosis. We aimed to assess the presence of early vascular dysfunction in patients with systemic onset juvenile idiopathic arthritis (sJIA) and investigate the role of therapy sJIA in vascular health. Thirty-three patients (22 males, 11 females) diagnosed with sJIA according to the International League of Associations for Rheumatology criteria were compared to 72 age- and sex-matched controls. None of the participants was overweight, obese, or had a history of hypertension, dyslipidemia, diabetes mellitus, or cardiovascular disease. Arterial stiffness (As) was evaluated by measurement of carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx) with a Vicorder. The mean age of patients in this study was 9.96 ± 3.71 years (range 4–16 years) and the mean age of controls was 10.9 ± 3.52 years (range 4–19 years). These two groups were well matched for age, sex, and BMI. The mean age of patients at the onset of disease was 7.06 ± 3.9 years (range 3–15 years). The mean duration of disease and active disease was 79 ± 45 months (range 6–162 months) and 58 ± 49 months (range 1–101 months), respectively. The highest levels of PWV and AIx were found in the patient group. Seven patients had had macrophage activation syndrome at presentation. In these patients, vascular changes were higher than other patients (6.30 ± 0.42 m/s vs 5.17 ± 0.55 m/s, p = 0.01, respectively). The corticosteroid therapy was found associated with higher PWV, (p < 0.05), while there was no difference between vascular parameters and use of non-steroid therapies (methotrexate (MTX), anti-TNF alfa agents). We also find statistically significant correlation between PWV and disease duration (p = 0.003, r = 0.45). Vascular function is impaired in patients with sJIA at a very young age. Vascular dysfunction may be partly attributed to the effects of disease-related characteristics (inflammation, disease activity, and medications).
Literature
1.
go back to reference Cassidy J, Petty R (2011) Chronic arthritis in childhood. In: Cassidy J, Petty R, Laxer R, Lindsley C (eds) The textbook of pediatric rheumatology, 5th edn. Sauders Elsevier, Philadelphia, pp 206–208 Cassidy J, Petty R (2011) Chronic arthritis in childhood. In: Cassidy J, Petty R, Laxer R, Lindsley C (eds) The textbook of pediatric rheumatology, 5th edn. Sauders Elsevier, Philadelphia, pp 206–208
2.
go back to reference Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26CrossRefPubMed Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104:13–26CrossRefPubMed
3.
go back to reference Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRefPubMed Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRefPubMed
4.
go back to reference Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27:174–182CrossRefPubMed Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27:174–182CrossRefPubMed
5.
go back to reference Gorska A, Rutkowska-Sak L, Musiej-Nowakowska E, Chlabicz S, Gorski S (2010) Nailfold videocapillaroscopy—a useful tool for screening patients with juvenile idiopathic arthritis at the risk of development of premature atherosclerosis. Postepy Hig Med Dosw (Online) 64:296–302 Gorska A, Rutkowska-Sak L, Musiej-Nowakowska E, Chlabicz S, Gorski S (2010) Nailfold videocapillaroscopy—a useful tool for screening patients with juvenile idiopathic arthritis at the risk of development of premature atherosclerosis. Postepy Hig Med Dosw (Online) 64:296–302
6.
go back to reference Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561PubMed Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561PubMed
7.
go back to reference Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L et al (2009) American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young: noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950CrossRefPubMed Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L et al (2009) American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young: noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950CrossRefPubMed
8.
go back to reference Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (2002) Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 61:167–170CrossRefPubMedPubMedCentral Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (2002) Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 61:167–170CrossRefPubMedPubMedCentral
9.
go back to reference De Benedetti F, Vivarelli M, Pignatti P, Oliveri M, Massa M, Pistorio A et al (2000) Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J Rheumatol 27:2246–2250PubMed De Benedetti F, Vivarelli M, Pignatti P, Oliveri M, Massa M, Pistorio A et al (2000) Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis. J Rheumatol 27:2246–2250PubMed
10.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
11.
12.
go back to reference Jednacz E, Rutkowska-Sak L (2012) Atherosclerosis in juvenile ıdiopathic arthritis. Mediators of Inflammation 1–5 Jednacz E, Rutkowska-Sak L (2012) Atherosclerosis in juvenile ıdiopathic arthritis. Mediators of Inflammation 1–5
13.
go back to reference Cesari M, Penninx BW, Newman AB et al (2003) Inflammatory markers and cardiovascular disease (The health, aging and body composition [health ABC] study). Am J Cardiol 92:522–528CrossRefPubMed Cesari M, Penninx BW, Newman AB et al (2003) Inflammatory markers and cardiovascular disease (The health, aging and body composition [health ABC] study). Am J Cardiol 92:522–528CrossRefPubMed
14.
go back to reference Rho YH, Chung CP, Oeser A et al (2009) Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 61:1580–1585CrossRefPubMedPubMedCentral Rho YH, Chung CP, Oeser A et al (2009) Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 61:1580–1585CrossRefPubMedPubMedCentral
16.
go back to reference Lin YT, Wang CT, Gershwin ME, Chiang BL (2011) The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10:482–489CrossRefPubMed Lin YT, Wang CT, Gershwin ME, Chiang BL (2011) The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10:482–489CrossRefPubMed
17.
go back to reference Stoner L, Young JM, Fryer S (2012) Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med 2012:1–9 Stoner L, Young JM, Fryer S (2012) Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med 2012:1–9
18.
go back to reference Aatola H, Hutri-Kahonen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T et al (2010) Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension 55:806–811CrossRefPubMed Aatola H, Hutri-Kahonen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T et al (2010) Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension 55:806–811CrossRefPubMed
19.
go back to reference Sozeri B, Deveci M, Dincel N, Mir S (2013) The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol 28(3):471–476CrossRefPubMed Sozeri B, Deveci M, Dincel N, Mir S (2013) The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol 28(3):471–476CrossRefPubMed
20.
go back to reference Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 34:1345–1352PubMed Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 34:1345–1352PubMed
21.
go back to reference Argyropoulou MI, Kiortsis DN, Daskas N, Xydis V, Mavridis A, Efremidis SC et al (2003) Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. Clin Exp Rheumatol 21:794–797PubMed Argyropoulou MI, Kiortsis DN, Daskas N, Xydis V, Mavridis A, Efremidis SC et al (2003) Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. Clin Exp Rheumatol 21:794–797PubMed
22.
go back to reference Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A et al (2015) Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis. Ann Rheum Dis 74:1515–1521CrossRefPubMed Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A et al (2015) Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis. Ann Rheum Dis 74:1515–1521CrossRefPubMed
23.
go back to reference Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res 63:1736–1744CrossRef Vlahos AP, Theocharis P, Bechlioulis A, Naka KK, Vakalis K, Papamichael ND et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res 63:1736–1744CrossRef
25.
go back to reference De Groot L, Posthumus MD, Kallenberg CG, Bijl M (2010) Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Investig 40:835–842CrossRef De Groot L, Posthumus MD, Kallenberg CG, Bijl M (2010) Risk factors and early detection of atherosclerosis in rheumatoid arthritis. Eur J Clin Investig 40:835–842CrossRef
26.
go back to reference Rho YH, Solus J, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM (2011) Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res 63(4):535–541CrossRef Rho YH, Solus J, Raggi P, Oeser A, Gebretsadik T, Shintani A, Stein CM (2011) Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res 63(4):535–541CrossRef
27.
go back to reference Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F et al (1994) Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 106(2):263–271CrossRefPubMed Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F et al (1994) Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 106(2):263–271CrossRefPubMed
28.
go back to reference Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19(10):2355–2363CrossRefPubMed Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO et al (1999) Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19(10):2355–2363CrossRefPubMed
29.
go back to reference Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsies patients. Am J Med 58:243–264CrossRefPubMed Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsies patients. Am J Med 58:243–264CrossRefPubMed
30.
go back to reference Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRefPubMed Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRefPubMed
31.
go back to reference Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M (2014) Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 53(12):2143–2154CrossRef Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M (2014) Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) 53(12):2143–2154CrossRef
Metadata
Title
Assessment of vascular function in systemic onset juvenile idiopathic arthritis
Authors
Betul Sozeri
Basak Yildiz Atikan
Kadriye Ozdemir
Sevgi Mir
Publication date
01-07-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3254-5

Other articles of this Issue 7/2016

Clinical Rheumatology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.